By HANA BORDAY , GMA News Published April 10, 2021 12:24pm The Food and Drugs Administration on Saturday said that the compassionate special permit for the use of anti-parasitic drug ivermectin as COVID-19 treatment is issued per patient. In an interview with "Dobol B TV," FDA director general Eric Domingo explained that an application is needed before the regulatory body can issue the compassionate special permit to a hospital. “Lahat po ‘yan bawat ospital kumukuha ng compassionate special permit kasi kontrolado po sa CSP kung ilang tableta, kung kaninong pasyente nila gagamitin, kung saan manggagaling na bansa, ano ang registration sa bansa na ‘yon” (hospitals need to get a CSP and it is patient-specific), he said.